Alzamend Neuro - 53 Year Dividend History | ALZN

Historical dividend payout and yield for Alzamend Neuro (ALZN) since 1971. The current TTM dividend payout for Alzamend Neuro (ALZN) as of May 24, 2024 is $0.00. The current dividend yield for Alzamend Neuro as of May 24, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.004B $0.000B
Alzamed Neuro is an early clinical stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Their mission is to rapidly develop and market safe and effective treatments. Their current pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
Stock Name Country Market Cap PE Ratio